GPX4, a classical inhibitor of ferroptosis, when down-regulated, can aggravate pulmonary fibrosis, liver fibrosis, and other fibrotic diseases by regulating autophagy, oxidative stress, and other pathways [47]. This evidence concerns the gene GPX4 and pulmonary fibrosis.